Author’s name | Year | CircRNAs (n = 13) | MMa patiens size | Sample type | Method | Survival indicator (OSb) | HR Extraction | Follow up* | NOSe | |
---|---|---|---|---|---|---|---|---|---|---|
HRc (95% CId) | P value | |||||||||
Fang Chen | 2020 | Circ-0069767 | 66 | Bone marrow | qRT-PCR | 0.22 (0.1–0.47) | 0.0001 | Indirectly | 60 | 7 |
Hongyan Ma | 2022 | Circ-PSAP | 50 | Bone marrow | qRT-PCR | 3.39 (0.99–3.88) | / | Indirectly | 60 | 7 |
Haiyan Liu | 2019 | Circ-SMARCA5 | 105 | Bone marrow | qRT-PCR | 0.259 (0.119–0.565) | 0.001 | Directly | 40 | 8 |
Lin Liu | 2021 | Circ-0001821 | 115 | Bone marrow | qRT-PCR | 2.342 (1.217–4.355) | 0.031 | Directly | 60 | 8 |
Fang Chen | 2020 | Circ-CDYL | 72 | Bone marrow and PBf | qRT-PCR | 3.49 (1.59–7.60) | 0.0017 | Indirectly | 60 | 7 |
Hui Zhou | 2019 | Circ-ITCH | 92 | Bone marrow | qRT-PCR | 0.367 (0.156–0.865) | 0.018 | Directly | 36 | 8 |
Xingxing Gong | 2021 | Circ- 0087776 | 136 | PB (serum) | qRT-PCR | 4.228 (2.564–6.974) | 0.001 | Directly | – | 7 |
Shanshan Yu | 2020 | Circ‑ MYBL2 | 89 | Bone marrow and serum | qRT-PCR | 0.37 (0.18–0.74) | 0.0052 | Indirectly | 50 | 6 |
Yanwei Luo | 2020 | Circ-MYC | 122 | PB (serum) | qRT-PCR | 3.67 (1.65–5.58) | 0.0001 | Directly | 60 | 8 |
Xiao Liu | 2020 | Circ-101,237 | 143 | Bone marrow | qRT-PCR | 4.22 (1.05–3.71) | 0.035 | Indirectly | 60 | 7 |
Fan Zhou | 2021 | Circ-PTK2 | 60 | Bone marrow | qRT-PCR | 3.89 (1.54–9.79) | 0.004 | Indirectly | 40 | 6 |
Fan Zhou | 2021 | Circ-AFF2 | 60 | Bone marrow | qRT-PCR | 0.29 (0.15–0.65) | 0.003 | Indirectly | 40 | 6 |
Yan Li | 2022 | Circ-KCNQ5 | 43 | Bone marrow | qRT-PCR | 7.96 (2.65–23.80) | 0.0001 | Indirectly | 60 | 8 |